| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 27, 2010First-To-Market Feature Allows Integration of Data from Multiple Vendors' 12-lead Management Systems
REDMOND, Wash., Apr 27, 2010 (BUSINESS WIRE) --Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), today announced the launch of Version 4.1 of its LIFENET System....
-
Apr 22, 2010
MINNEAPOLIS, Apr 22, 2010 (BUSINESS WIRE) --Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA) has...
-
Apr 7, 2010Hydrodebrider System Offers Innovative Treatment for Chronic Sinusitis that Affects Nearly 30 Million US Adults1
MINNEAPOLIS, Apr 07, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) announced today the launch of a new Frontal Handpiece for its Hydrodebrider(TM) System, manufactured by the company's Ear Nose and...
-
Mar 16, 2010Partnerships with American College of Cardiology and Association of Black Cardiologists and Latest Data from IMPROVE HF Clinical Study All Aim to Drive Equitable Treatment
MINNEAPOLIS & ATLANTA, Mar 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced Every Patient First, a health equity initiative that, in partnership with health care providers,...
-
Mar 10, 2010Offering Surgeons the Next Generation of Occipitocervical Upper-Thoracic Fixation
MEMPHIS, Tenn., Mar 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System. When a patient has a spinal condition...
-
Feb 23, 2010Non-GAAP diluted EPS of $0.77 grew 8%; GAAP diluted EPS of $0.75 grew 21%International revenue of $1.615 billion grew 11% on a constant currency basis; 22% as reportedFree cash flow exceeds $1.3 billion; GAAP cash flow from operations of $1.488 billionWorldwide ICD revenue growth of 5% on a constant currency basis; 9% as reportedWorldwide CardioVascular revenue growth of 21% on a constant currency basis; 28% as reported
MINNEAPOLIS, Feb 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010. The company...
-
Dec 18, 2009
MEMPHIS, Tenn., Dec 18, 2009 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the SOVEREIGN(TM) Spinal System. The SOVEREIGN Spinal System is an intervertebral...
-
Nov 24, 2009Non-GAAP diluted EPS of $0.77 grew 15%; GAAP diluted EPS of $0.78 grew 63%
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 24, 2009-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2010, which ended Oct. 30, 2009. The company...
-
Nov 17, 2009A Spinal System That Offers Two Screw Designs for Enhanced Fixation
MEMPHIS, Tenn.--(BUSINESS WIRE)--Nov. 17, 2009-- Medtronic, Inc. (NYSE: MDT), today announced the launch of the TSRH® 3Dx™ Spinal System. Designed with procedural efficiency in mind, the TSRH...
-
Aug 22, 2006
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 22, 2006--Medtronic, Inc. (NYSE:MDT): -- Reported earnings of $599 million and diluted EPS of $0.51 grew 87% and 96%, respectively over the prior year's quarter....
-
Jun 2, 2006
MINNEAPOLIS--(BUSINESS WIRE)--June 2, 2006--Medtronic, Inc. (NYSE:MDT) will host an analyst and investor briefing Monday, June 12, 2006 in Washington D.C., during the American Diabetes Association...
-
May 23, 2006
MINNEAPOLIS--(BUSINESS WIRE)--May 23, 2006--Medtronic, Inc. (NYSE:MDT): Annual Revenue of $11.3 Billion Grew 12% (13% Constant Currency Growth); Fourth Quarter Revenue of $3.1 Billion Grew 11%...
-
May 24, 2005
Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues of $682 million in the Quarter Increases Medtronic Worldwide ICD Market Share to 50 Percent -- Spinal Business...
-
Aug 18, 2004
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 18, 2004-- Broad Based Growth Was Led By 31 Percent Increase In Quarterly Implantable Defibrillator Revenues Medtronic, Inc. (NYSE:MDT) today announced quarterly...
-
May 4, 2004
MINNEAPOLIS--(BUSINESS WIRE)--May 24, 2004--Medtronic, Inc. (NYSE:MDT) today announced record quarterly revenues of $2.665 billion, an increase of 24.1 percent over the $2.148 billion of the...
-
Feb 10, 2004
MINNEAPOLIS--(BUSINESS WIRE)--Feb. 11, 2004-- Record Quarterly Performance Led by Greater Than 15 Percent Growth in Spinal, Implantable Defibrillators, Diabetes and Vascular Drawing upon the...
-
Nov 12, 2003
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 12, 2003-- Record Quarter Led by Continued Strong Growth in Implantable Defibrillator and Spinal Revenues, Together With Accelerated Growth in Diabetes; All...
-
Aug 12, 2003
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 12, 2003-- Continued Strong Performances in Cardiac Rhythm Management, Spinal and Neurological Spur Growth Continuing to benefit from widespread acceptance of...
-
Nov 17, 2001Spinal Products and Implantable Defibrillators, Two of Medtronic's Largest Product Lines, Led Second-Quarter Growth
MINNEAPOLIS, Nov 17, 2004 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced quarterly net earnings of $535.7 million, or $0.44 per diluted share, an increase of 13 percent over the...